BURLINGAME, Calif.–(BUSINESS WIRE)–Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, today reported data demonstrating the increasing prevalence of essential tremor (ET) from 2010 to 2018; a high rate of depression and anxiety in patients with ET; and the safety and efficacy of Cala Trio when used in a real-world setting […]

Learn About the Cala Trio in Our New Podcast; Take Our Tremor Talk Survey; Scholarship Applications Due October 31.

Categories: Tremor Gram
Posted on October 8, 2020

It’s a watch-like device that stimulates nerves in the wrist to interrupt, and therefore, calm tremors in the hands. Listen to this conversation about the Cala Trio from Cala Health CEO Renee Ryan.  

Categories: Podcasts
Posted on July 17, 2019

Patient recruitment is usually the biggest challenge in conducting clinical trials. Thanks to the International Essential Tremor Foundation and their members, Cala Health recently enrolled the largest therapeutic essential tremor study in record time. By Kate Rosenbluth,Founder/CEO of Cala Health, Inc. About five years ago, my co-founders and I spun Cala Health out from Stanford […]

Posted on August 1, 2018

Manish Gupta has over 15 years of experience in developing and executing global clinical trials in cardiac and neurological devices (including those developed to manage essential tremor). He shares how clinical trials work and how the IETF partners with Cala Health to recruit participants.  By Manish Gupta Vice President of Clinical Affairs Cala Health, Inc. […]

Categories: ET News, Research Study